Accumulating Barriers to Care: Double Jeopardy for US Patients
Dan Leonard, Kimberly Westrich, and Brian Sils of the National Pharmaceutical Council examine how a new HHS ruling on how US patients pay for…
Tagged with Opinion
Exploring New & Repurposed Tools in the Fight Against…
Dr Sophia Ononye-Onyia explains why a combination of both repurposed drugs and emerging technologies like 3D bioprinting and artificial intelligence…
Opinion: The Chinese Doctor-Patient Relationship in the Digital…
I recently had the pleasure to moderate an event on the COVID-19 impact on the relationship between Doctor and Patient, attended by 50 executives of…
Key Challenges for Life Sciences & Healthcare in 2020:…
‘The Key Challenges: Life Sciences and Healthcare 2020’ is the latest report from Cornerstone International Group based on a global survey of…
“Medication Adherence” is a Lunatic Endeavour
John G. Singer outlines why a focus on patients’ adherence to their medication is not necessarily useful in working to improve health outcomes…
Key Challenges for Life Sciences & Healthcare in 2020:…
‘The Key Challenges: Life Sciences and Healthcare 2020’ is the latest report from Cornerstone International Group based on a global survey of…
Putting People Ahead of the Maths: Addressing the Limitations of…
Mike Glover, Vice President Global Head of Access and Pricing Strategy Oncology at GSK outlines that while new mathematical approaches to health…
Drones are Taking Off in Healthcare
Brendan Shaw takes a look at the rise of drone technology in medical product delivery and its implications for the future of healthcare. What…
Speeding up the Search for Safe & Effective COVID-19…
IFPMA Director General Thomas B. Cueni shares the outcomes of a recent high level pharma industry media briefing on the search for a COVID-19…
Standing on the Shoulders of Giants: The Art & Science of…
DataArt’s Daniel Piekarz looks at how machine learning and artificial intelligence can play into the important task of drug repurposing,…
Worried About Biogen’s Aducanumab? Don’t Be
Dr Neil Cashman examines the recent news around Biogen’s Alzheimer’s treatment aducanumab, assuages some investor fears, and underlines…
Forging Connections & Trust – At A Safe Social…
Takeda’s Head of R&D Patient Engagement Jessica Scott examines the parallels between partnering with patients and working remotely with…
